Search results
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 12 hours agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
EU to secure 40 million avian flu vaccines for 15 countries – officials
WHTC 1450 Holland· 5 days agoBy Julia Payne BRUSSELS (Reuters) - The EU will sign a contract on Tuesday to secure over 40 million...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News· 5 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna,...
Another COVID vaccine? Yes, and here’s why
San Jose Mercury News· 4 days agoThis fall, prepare for the latest round of COVID vaccine Whac-a-Mole. Protection against both infection and severe illness is waning. “Effectiveness has...
Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine
Clinical Trials Arena via Yahoo Finance· 3 days agoAt this time, mRNA-1083 is poised to be the first Covid-19/influenza combination vaccine and the...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
Morningstar· 5 days agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID vaccines in adults 50 years and older, including an ...
Moderna says its combination COVID and flu vaccine tested better than separate shots
CBS News· 5 days agoModerna announced Monday that its combination COVID and flu vaccine showed positive results in a...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 3 days agoFurther, Moderna confirmed it's in discussions with the U.S. government to move forward with its...
Moderna's combo Covid, flu vaccine meets goals in late-stage study - Boston Business Journal
The Business Journals· 5 days agoModerna Inc. is making steady headway on its plan to launch all four products from its respiratory...
Why Moderna Stock Is a No-Brainer Buy Right Now
Motley Fool via Yahoo Finance· 5 days agoAnd there could be more to come -- much more. The company has already announced positive results from a late-stage study of its influenza vaccine...
